anmelden
NYSE International 100
10.772,43
PKT
+1,96
PKT
+0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.10.19 | Telefonica Equal weight | Barclays Capital | |
| 23.10.19 | Novartis Neutral | Credit Suisse Group | |
| 23.10.19 | Novartis Underweight | Barclays Capital | |
| 24.10.19 | Prudential Neutral | JP Morgan Chase & Co. | |
| 23.10.19 | Prudential Neutral | JP Morgan Chase & Co. | |
| 23.10.19 | SAP Halten | Independent Research GmbH | |
| 23.10.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 23.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | SAP Neutral | UBS AG | |
| 23.10.19 | GSK Neutral | UBS AG | |
| 23.10.19 | SAP Neutral | Oddo BHF | |
| 23.10.19 | Mercedes-Benz Group (ex Daimler) Sell | Goldman Sachs Group Inc. | |
| 23.10.19 | BP overweight | JP Morgan Chase & Co. | |
| 23.10.19 | TotalEnergies overweight | JP Morgan Chase & Co. | |
| 23.10.19 | Eni Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.19 | AXA overweight | JP Morgan Chase & Co. | |
| 22.10.19 | SAP overweight | Barclays Capital | |
| 22.10.19 | SAP Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.19 | Deutsche Bank Neutral | Goldman Sachs Group Inc. | |
| 22.10.19 | SAP Outperform | Credit Suisse Group | |
| 22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | UBS buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | SAP buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.10.19 | SAP Neutral | UBS AG | |
| 22.10.19 | Telefonica Neutral | UBS AG | |
| 22.10.19 | Novartis buy | Jefferies & Company Inc. | |
| 22.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | Siemens overweight | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Neutral | UBS AG | |
| 22.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.10.19 | HSBC Neutral | UBS AG |